Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02556749 · ClinicalTrials.gov registry record · NA

Effects of Cranberry Juice on Cardiovascular Risk Factors

A NA study, sponsored by Penn State University.

Completed
Registry status
NA
Development phase
47
Enrollment target

NCT02556749 is a NA study that has completed, run by Penn State University. The registered enrollment target is 47 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02556749, a NA study, has completed, sponsored by Penn State University.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the effects of cranberry juice on central and peripheral blood pressure, indices of arterial stiffness, lipid and lipoprotein concentrations and size characteristics, and HDL function. The investigators hypothesize that the bioactive compounds in cranberry juice may elicit beneficial effects on blood pressure and arterial health, as well as LDL-C and HDL function.

Interventions

  • DIETARY_SUPPLEMENT Placebo Beverage
  • DIETARY_SUPPLEMENT Cranberry Juice Beverage

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2015-10
Est. Completion 2019-05
Phase NA

Sponsor

Penn State University

219 total trials

What the Registry Record Tells You About NCT02556749

The ClinicalTrials.gov registry entry for NCT02556749 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo Beverage is the first listed.

NCT02556749 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02556749 about?

NCT02556749 is a clinical study titled "Effects of Cranberry Juice on Cardiovascular Risk Factors". The purpose of this study is to evaluate the effects of cranberry juice on central and peripheral blood pressure, indices of arterial stiffness, lipid and lipoprotein concentrations and size characteristics, and HDL function. The investigators hypothesize that the bioactive compounds in cranberry ju...

What is the current status of trial NCT02556749?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2015-10. Estimated completion is 2019-05.

What interventions are being tested in trial NCT02556749?

The interventions under investigation include: Placebo Beverage (DIETARY_SUPPLEMENT), Cranberry Juice Beverage (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02556749?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.